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ABSTRACT 
A highly sensitive, specific, real time, and field-deployable surveillance tool is 
critical to the control of pathogens and infections, as well as ecological impact of chemicals 
exposure. This work investigates the development of a low cost biosensing platform that 
can be used for viral disease diagnosis and chemical detection. The sensing mechanism is 
known as AC electrokinetics (ACEK) capacitive sensing. By applying an inhomogeneous 
AC electric field on sensor electrodes, positive dielectrophoresis is induced to accelerate 
the travel of analytes. The same applied AC signal also directly measures the capture of 
target by the probe on sensor surface. The realized sensing platform is not only rapid but 
also highly sensitive and specific. Built on our initial proof-of-concept of ACEK capacitive 
sensing, this work studies in details the immobilization of probes on electrode surface, 
electrode design, the interactions between biomolecules such as nucleic acids and testing 
buffers, and the effect of dielectrophoresis and accompanying ACEK phenomena. 
Experimental comparisons are made between sensors with various probe immobilization, 
different electrode designs, testing buffer and detection protocols. As a result, much higher 
sensitivity and selectivity have been achieved. We are able to successfully detect virus 
particles in nasal swab samples, specific antibody in serum and whole genome nuclei acids 
in serum. To extend the application of this sensing method on other electrode platform, 
polyimide-based laser printed electrodes are also investigated and successfully 
demonstrated for small molecule detection. However, this type of sensor exhibits high 
internal resistance, making it only suitable for chemical or particle detection in highly 
resistive electrolyte, such as de-ionized water. With procedural and design improvements 
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discussed in this work, it is expected that ACEK capacitive sensing will become a 
disruptive technology in on-site biochemical detection.  
Keywords: capacitive sensing, ACEK, point of care, virus, protein, nucleic acid. 
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CHAPTER 1 
INTRODUCTION 
1.1 History, development and challenges of biosensor 
The field of biosensor, in the past 60 years, has undoubtedly attracted a great 
amount of research and development efforts. Researchers and scientists from chemistry, 
physics, microbiology, as well as various disciplines of engineering have been deeply 
involved in this interdisciplinary field. In 1956, Professor Leland C. Clark publishes his 
monumental paper on the development of an oxygen probe using the enzyme glucose 
oxidase (GOX) in transducer in measurement of glucose. In 1962 he described how “to 
make electrochemical sensors (pH, polarographic, potentiometric or conductometric) more 
intelligent” by adding “enzyme transducers as membrane enclosed sandwiches”[1]. 
Professor Clark is the inventor of the Clark electrode, which a device used for measuring 
oxygen in blood, water and other liquids[2]. He is considered as the "father of biosensors" 
and the modern-day glucose sensor used daily by millions of diabetics is based on his 
research. 
Biosensor today is either sophisticated, high-throughput laboratory machine 
capable of rapid, accurate and convenient measurement of complex biological interactions 
and components or easy-to-use, portable device for use by non-specialists for decentralised, 
in situ or home analysis. The former are expensive and the latter are mass produced and 
inexpensive.[3] 
Expansion of human activities and process of globalization speed up the high pace 
of people’s life and engagement, as well as the spread of pathogens and their vectors. 
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Influenza, for instance, is a very common infectious disease. While it usually causes only 
mild illness, it can be life-threatening for infants, elderly and immunodeficient people. 
Worldwide, seasonal influenza is estimated to cause 250,000–500,000 deaths per year. 
Historically, influenza caused pandemic such as the Spanish flu pandemic of 1918. Recent 
years, worldwide human health has been challenged by pandemic threats such as the 
emergence of highly pathogenic influenza A virus from mutation of avian influenza or 
other animal reservoirs. It is well established that timely diagnosis of viral infection can 
shorten the delay in treatment, reduce the duration of hospitalization, and improve the 
quality of patient care. Recently, the potential health consequences of Zika virus infection, 
and the lack of effective treatment for the disease, the World Health Organization (WHO) 
declared a public health emergency and released a call for the development of new 
diagnostic tests for Zika virus infection. Zika virus is a flavivirus (family Flaviviridae) that 
was first identified in Nigeria in 1947.[4] Many people infected with Zika virus were either 
asymptomatic[5] or reported having only mild, nonspecific influenza-like symptoms, such 
as fever and headache. Most patients typically recover within several days to a week.[6] 
However, the viral infection occasionally causes severe manifestations, including Guillain-
Barre syndrome, in adults and microcephaly in babies when the mother has been infected 
with the virus during pregnancy. There also has been increasing concerns regarding the 
potential risk of sexual transmission of Zika virus during pregnancy.[7] Therefore, a rapid 
point of care (POC) diagnosis for infectious diseases outside hospital is desired and will 
have significant impact on the healthcare.  
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Despite for the area of infectious diseases detection, recent years have also seen a 
growing need to monitor and rapidly detect contaminants in the environment and food 
supply such as bisphenol A (BPA). BPA is a monomer widely used in a variety of consumer 
products, including plastics, food packaging, dental sealants, and thermal receipts. It was 
reported that 8-15 billion pounds of the material were produced annually[8]. Because of 
the widespread use of BPA, the compound has been detected in aquatic environments, 
which are considered the ultimate reservoirs for environmental anthropogenic chemicals. 
BPA is a known endocrine disruptor with estrogenic, antiandrogen properties and can 
disrupt thyroid function. Studies have demonstrated that BPA can have significant 
biological effects at low, environmentally relevant doses[9],[10]. Significant levels of BPA 
have been detected in river water, river sediments, and fish muscles. In particular, there is 
concern that the consumption of fish could contribute to the total intake of BPA in human 
populations. Detection and quantification of BPA concentrations in water are critical for 
the U.S. Environmental Protection Agency to develop water quality standards and to 
evaluate environmental risk levels for the protection of human health. The majority of 
current BPA detection methods rely on high performance liquid chromatography (HPLC) 
or enzyme-linked immunosorbent assay (ELISA), which require the use of costly 
instruments by skilled personnel with complex and time-consuming operation[11]. 
Therefore, a simple and affordable method to monitor BPA level in environmental samples 
with high sensitivity remains critical. 
Similar to the need of simple and easy-to-use method to detect BPA, interest of 
developing detection method of influenza is also growing. Currently, accurate diagnosis of 
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influenza virus is done by either virus isolation, detection of virus-specific antibodies or 
genomic detection by reverse-transcription polymerase chain reaction (RT–PCR). Virus 
isolation and antibody tests take several days and can hardly meet the time-sensitive needs 
of patient management. Real-time RT–PCR-based molecular assays can yield results in 
hours and are being increasingly used for early diagnosis. However, real-time RT-PCR 
requires good financial and technical resources to perform, often restricted to central 
laboratories. 
1.2 Improvement on capacitive sensing 
Previously, our group has developed an AC electrokinetics-based capacitive 
sensing method with microfabricated interdigitated electrodes that could reach a limit of 
antigen-antibody detection of 10 ng/ml. With adoption of cross linker during electrodes 
functionalization and studies on immobilization and testing buffers, the limit of detection 
(LOD) are improved significantly to pg/mL level and the sensing platform is expanded to 
nucleic acid and chemical detections. In addition, by researches on the various designs of 
electrodes, compatibility of ACEK sensing method was studied to support rapid and low 
cost prototyping and manufacturing, and AC electroosmotic effect is also utilized for 
capacitive sensing, expanding the varieties of ACEK capacitive sensing.  
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CHAPTER 2 
LITERATURE REVIEW 
The clear and enormous need for healthcare and environmental monitoring 
continues to drive substantial research in the field of biosensor. The last three decades have 
witnessed the remarkable development and progress of sophisticated and accurate 
traditional laboratory based sensing instrumentations. Although both high throughput 
sensing in traditional laboratory based sensing instrumentation and of low cost sensing for 
field or personal use are highly demanded, the need for low cost sensing for healthcare and 
environmental monitoring, for example, has particular benefit to developing economies, in 
particular within Africa and South East Asia[12]. There are special needs for low-cost 
point-of-care (POC) diagnostic and monitoring tools due to the lack of suitable testing 
clinics and facility. Additionally, while considerable research effort has been devoted to 
biosensors for diagnosis at the bedside or in the clinic, there have been few successful 
devices being routinely used in real applications.  
While considerable research effort has been devoted to biosensors for diagnosis at 
the bedside or in the clinic, there are few successful POC devices being routinely used in 
real applications. POC diagnostic systems require the following critical attributes: 
sufficient sensitivity, robustness, simple test procedure and short sample-to-result time. 
Recent progress in the development of such systems has been fueled by rapid innovations 
in microfluidics, miniaturization, and enhanced signal detection technologies. Current POC 
diagnostics, based primarily on immunoassay technologies, have been the mainstream 
application for decades. However, traditional immunoassay technologies are not very 
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sensitive and need a long time to yield result, which limits the applicability of these tests 
to many clinical conditions. The obstacle to achieving rapid detection is the long diffusion 
time for the target bioparticles to reach the sensing site of a sensor. So accelerating the 
diffusion process has been an essential part of the study. Most of the reported biomolecular 
sensors work with heavily processed samples, requiring purification, pre-concentration, 
etc. in addition to sophisticated data processing and expensive equipment. Another 
challenge is specificity. A number of ultrasensitive immunosensing methods have been 
developed, many based on nanotechnology. However, only a few of the newer 
ultrasensitive methods have been evaluated with real patient samples, which is key to 
establishing clinical sensitivity and selectivity. 
2.1 Electrochemical enzymatic biosensors 
Electrochemical biosensors have traditionally received the major share of the 
attention in biosensor development[13]. Due to the simple, inexpensive and yet accurate 
and sensitive platform electrochemical biosensors have provided, they have always been a 
major role in the move towards simplified testing, including home-use devices[14]–[17]. 
Being capable of mass production with low cost and adequate accuracy and 
sensitivity are major criteria for successful commercialization of POC sensors and devices. 
Categorized as amperometric sensors, the electrochemical glucose sensors have attracted 
the most attention due to the sensors’ unbeaten sensitivity and selectivity, even though 
numerous processes and methodologies have been developed for creating new glucose 
biosensors such as electrochemical methods[18], colorimetry[19], conductometry[20], 
optical methods[21], and fluorescent spectroscopy[22]. The portable glucose biosensors 
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which only requires a 0.3- to 1.5-μL drop of blood and usually take less than 10 seconds 
for the result have achieved the most significant commercial success[23]. Amperometric 
biosensors function by the production of a current (typically in nA to μA range) when a 
potential is applied between two electrodes. 
2.2 Labeled affinity biosensor 
Affinity biosensor measures the affinity between bioreceptors and target analyte, 
and lableded affinity biosensor uses label molecular to help detect the target. For example, 
fluorescence labeling[24],[25], radiolabeling or isotope labeling, etc. Introducing 
microfluidics into POC systems attracts increasing interest and offers new ways and 
methods for POC diagnostics[26]. ELISA (enzyme-linked immunosorbent assay)[27] is a 
plate-based assay technique designed for detecting and quantifying substances such as 
peptides, proteins, antibodies and hormones. A detection enzyme or other tag can be linked 
directly to the primary antibody or introduced through a secondary antibody that recognizes 
the primary antibody. Detection is accomplished by assessing the conjugated enzyme 
activity via incubation with a substrate to produce a measurable product. Since the 
traditional ELISA relies on diffusion of the reactants to the antibodies immobilized on the 
microwell surface, the incubation times can be as long as a few days per assay. A strategy 
to reduce the assay time lies in reducing the well volume while increasing its surface area, 
which leads directly to miniaturization and microfluidic integration[28]–[34]. 
Microfluidics can improve the sensitivity, speed, and reduce costs of an immunoassay over 
ELISA by overcoming the issues of the large sample volume, long assay duration and low 
sensitivity. By employing a bead-based immunoassay in a microfluidic channel, Sato et al. 
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reported to shorten an immunosorbent assay overall time from 24 hr to less than 1 hr with 
a limit of detection of 1 µg/ml[35]. To lower the cost of the sensing platform, Microfluidic 
Paper-based Analytical Devices (µPADs)[36], [37] is another option. Paper itself has 
advantages like being inexpensive, flexible, light weight, disposable, compatible with 
biological samples, and can be easily modified by chemicals. Since capillary force in wet 
paper could be the mainly driving force for fluids flow delivery, complicated supporting 
pump is not necessary. This allows biosensors to be more readily transformed in lab-on-a-
chip with capillary microfluidics[38]. Nevertheless, drawbacks like low limit of detection 
and sensitivity, immaturity of paper based devices and losing activity of bioreceptors with 
time limit the application of µPADs.  
2.3 Label-free affinity biosensors 
Labeled biosensors require a label attached to the target for signal amplification 
purposes and during readout the amount of label is detected and assumed to correspond to 
the number of bound targets. However, steps such as labeling a biomolecule would increase 
the complexity and time of sensor operation, drastically change its binding properties, and 
the yield of the target-label coupling reaction can be highly variable[39]. Being label-free, 
thus eliminating the need for labeling (fluorescent, chemical, or radioisotope) target 
molecules, is important.  
Surface plasmon resonance (SPR)[40],[41] based label-free biosensor can be 
utilized to detect bioparticles reactions such as protein binding[42],[43] and hybridization 
of different types of nucleic acids[44]. Figure 1[45] shows the configuration of an SPR 
device. The surface plasmons (SPs) is a free charge oscillation that exist at the interface  
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Figure 1 Configuration of an SPR device. SPR’s wave-matching condition is very easily 
disrupted by even very tiny changes in the interface conditions.[45] 
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between any two materials[46]. A fraction of the light energy incident at a sharply defined 
angle can interact with the delocalized electrons in the metal film (plasmon) thus reducing 
the reflected light intensity. In Figure 1, a single wavelength laser beam enters a prism 
which results in many light angles striking the metal surface, all of them are reflected 
except for the angle in which the metal will absorb and turn its energy into a plasmon wave 
onto its outer surface, at this angle no light is reflected and thus appears with very little 
intensity on the detector. Since the plasmon wave propagates on the outer side of the metal, 
any interaction with the conjugated protein will change the resonance angle[45]. The SPR 
biosensors have been widely applied in a diverse range of fields, including molecular 
recognition, and disease immunoassays, etc.[47]–[52] 
Impedance spectroscopy is another example of label-free strategy for transducing 
biological recognition events[53]. It has been widely used for probing various types of 
biomolecular interactions such as immunosensors, DNA hybridization, rapid biomolecular 
screening, cell culture monitoring, etc.[54]–[57], since Newman and Martelet[58] who 
come up with the concept of impedimetric based immunosensors. So far, impedimetric 
immunosensors have been successfully applied at the academic level. However, no 
prototypes have been released into the market and this fact has brought the reliability of 
them into question. 
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CHAPTER 3 
AC ELECTROKINETICS 
ACEK effects, including dielectrophoresis (DEP), ACEO and ACET effects, are 
increasingly used in microfluidic devices to manipulate fluids and embedded objects[59]. 
DEP directly acts on the particles embedded in the fluid, while ACEO and ACET effects 
induce fluid movements that carry the embedded particles. ACEK effects improve the 
sensor sensitivity and response time by accelerating the travel of target molecules to the 
electrode surface[25],[60],[61].  
3.1 Dielectrophoresis 
Dielectrophoresis, or DEP, refers to the interaction between a dipole moment on a 
particle and a non-uniform field[62]. This technique has been studied in great details for 
controlled manipulation of particles, binary separation, and characterization of particles. 
The DEP force on a spherical particle can be described as followed[63],  
𝐹𝐷𝐸𝑃 = 𝜋𝜀𝑚𝑎
3Re [
𝜀𝑝
∗ −𝜀𝑚
∗
𝜀𝑝
∗ +2𝜀𝑚
∗ ] ∇|𝐸|
2 = 𝜋𝜀𝑚𝑎
3Re[𝐾(𝜔)]∇|𝐸|2                                       (3.1) 
where 𝜀𝑚 is the medium permittivity, 𝑎 is the radius of the particle, 𝜀𝑝
∗  and 𝜀𝑚
∗  are particle 
and medium complex permittivity respectively.  
Complex permittivity is defined as 𝜀∗ = 𝜀 − 𝑗
𝜎
𝜔𝜀
 (σ: conductivity; ω angular 
frequency). 𝐾(𝜔), a function of ω, is also known as Clausius–Mossotti factor. Therefore, 
the DEP force 𝐹𝐷𝐸𝑃 is frequency dependent. In the context of electrokinetic manipulation, 
the real part of the Clausius–Mossotti factor is a determining factor for the dielectrophoretic 
force on a particle. For Re[𝐾(𝜔)] > 0  (or <  0 ), 𝐹𝐷𝐸𝑃 > 0 (or < 0)  and positive (or 
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negative) DEP will be applied on the particle. Since positive DEP force on a particle traps 
the particle at the surface of electrodes while negative DEP repels the particle away from 
the electrodes, in this work, positive DEP would be applied to accelerate the binding 
reaction between virus and antibody. As is shown in Equation 3.1, 𝐹𝐷𝐸𝑃 depends on the 
particle volume. For nanoscale macromolecules, DEP may not be effective unless the 
molecules are located within a very short distance to the electrodes (<1 mm).  
3.2 AC Electroosmosis 
ACEO effect can induce microfluidic vortices above electrodes to transport target 
molecules to the electrode surface for binding[64]–[67], which improves the detection 
sensitivity and response time. ACEO typically dominates at low ionic strengths, such as 
target samples diluted in water. But the flow velocity of ACEO has been observed to 
decrease significantly with increasing conductivity and eventually drop to zero above 0.085 
S/m[68]. Hence for medical and biological applications involve the use of solution with 
high conductivity the ACEO flow will be negligible. ACEO flows are caused by the 
movement of induced charges in the EDL at the solid-liquid interface when a non-uniform 
AC electric field is applied. The induced counter-ions will move under a tangential electric 
field to generate ACEO flows. ACEO fluid velocity is approximately given as 
𝑢𝐴𝐶𝐸𝑂 = −
𝜀𝑚
𝜂
∙ 𝛥𝜉 ∙ 𝐸𝑡                                                                                                    (3.2) 
where 𝜺𝒎 and 𝜼 are the permittivity and viscosity of the medium, 𝑬𝒕 is the component of 
the electric field strength tangential to the electrode surface, and 𝜟𝝃 is the voltage drop 
over the interfacial layer including the EDL and molecular deposition at the electrode 
surface[63]. ACEO velocity is known to exhibit a bell-shaped dependence on frequency 
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due to the charging process of EDL. Therefore, the frequency of capacitive sensing needs 
to be optimized to maximize ACEO effect. 
3.3 AC electrothermal effect 
ACET effect arises from uneven Joule heating due to an electric current flowing 
through the fluid. Once the AC electric field is applied in the bulk solution, polarized 
particles would be separated and migrate, which generates the ionic current. The time 
average electric thermal force is shown in Equation 3.3, 
𝐹𝐸𝑇 = −0.5 [(
∇σ
σ
−
∇𝜀
𝜀
) 𝐸
𝜀𝐸
1+(𝜔𝜏)2
+ 0.5|𝐸|2∇𝜀]                                                             (3.3) 
where 𝐸 is the electric filed strength, 𝜔 is the frequency of the applied excitation, 𝜀 and σ 
are medium permittivity and conductivity respectively, 𝜏 = 𝜀 σ⁄  is the charge relaxation 
time. 
Separation of the electrodes used in our tests is around 2 um, which leads to a quite 
low ACET force that can also be neglected. As a result, the only dominated force for target 
virus concentration is the DEP force, which is calculated to be 2.25×10−17𝑁, leading to a 
fluid velocity of 47.5nm/s. 
3.4 Capacitive sensing 
When immersed into fluid, the interdigitated electrode cell can be electrically 
represented by an equivalent circuit. The circuit shown in Figure 2 consists of the 
electrode’s self-resistance (Rwire), interfacial capacitance (Cint), charge transfer resistance 
(Rct), solution bulk resistance (Rs) and dielectric capacitance of the electrode cell (Cs). 
The interfacial capacitance is a combination of electric double layer (EDL) and deposited 
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Figure 2 Equivalent circuit for a pair of sensor electrodes in fluid. 
  
 
15 
bioparticles capacitance and is expressed as in Equation 3.4, 
𝐶𝑖𝑛𝑡 =  𝐴𝑖𝑛𝑡 (
1
𝜀𝑝
𝑑𝑝 +
1
𝜀𝑠
𝑑𝑒𝑑𝑙)⁄                                                                                       (3.4) 
where Aint is the surface area of the interfacial capacitor of the functionalized electrode, dp 
and dedl are the thickness of bioparticle immobilized and electric double layer formed on 
the electrodes surface respectively, εp is the bioparticle permittivity and εs is the solution 
permittivity. When bioparticles are immobilized on the surface and binding reaction 
occurs, dp will increase and therefore result to the interfacial capacitance to reduce.  
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CHAPTER 4 
ELECTRODES FOR DIRECT CAPACITIVE BIOSENSING 
The sensing platform in this work is based on AC electrokinetics (ACEK) 
capacitive sensing technology.[69] It adopts low cost interdigitated microelectrodes 
functionalized with a capture bioreceptor targeting the pathogen bioparticles that need 
detection. During the assay, an AC signal is applied onto the microelectrodes to induce 
microfluidic phenomena by ACEK effects that cause targets in the sample solution applied 
on electrodes to move towards the electrode surface and bind with the immobilized 
bioreceptor. The binding causes a change in the interfacial capacitance (Cint) at sensor 
surface, and is detected electrically using the same ACEK signal.  
4.1 Various interdigitated electrodes 
4.1.1 Surface acoustic wave (SAW) resonators 
The Surface Acoustic Wave (SAW) electrode chips used in our ACEK capacitive 
assay are modified from AVX Corps’ PARS 433.92 chip. The metal cover of the SAW 
resonator is removed mechanically to expose the working electrode array for use, as shown 
in Figure 3. The detection surface consists of aluminum electrodes deposited on quartz 
substrate. Each electrode finger is 2.0 μm wide, 170μm long, with 1.5 μm spacing from 
each other. The metal housing around the electrode chip is about 4mm (L) x 2.5mm (W) x 
1mm (H), and accommodates ~10µL of sample. The interdigitated electrodes are 
electrically connected to two contact pads on the chip bottom, which are then connected to 
an impedance analyzer (Agilent 4294A). 
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Figure 3 Commercially available Surface Acoustic Wave (SAW) electrode chip. 
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4.1.2 Copper-based gold electroplated electrodes 
The copper-based gold electroplated printed circuit board (PCB) electrodes shown 
in Figure 4 are fabricated by chemical etching method. Electrode finger is 400 µm wide 
and 200 µm in separation. Pattern of electrodes is printed on toner transfer paper in ink and 
then transferred onto the copper sheet by using laminator whose temperature is set to be 
379°F. After being slipped into water to release the paper from image picture, the board is 
cleaned and dried, toner reactive foils are applied to seal the toner image against the etchant, 
resulting in a perfectly etched image. With the ink sealed and protected by toner reactive 
foils, the patented copper sheet is then immersed into copper etchant, or ferric chloride 
(MG Chemicals), which is heated to 55°C (135°F). After etching the board, toner reactive 
foils and underlying toner are removed by wiping down the board with Acetone.  
4.1.3 Microfabricated gold electrodes  
Microfabricated gold electrodes shown in Figure 5 are using lift-off method. 30 nm 
gold layer is deposited on the 10 nm chromium adhesion layer and then the 500 nm silicon 
dioxide layer. Each gold electrode finger is 4 µm wide and 4 µm spacing in between each 
other. 
4.2 Design consideration of interdigitated electrodes 
The suitability of an IDE can be evaluated by extracting the equivalent circuit of 
the IDE. Figure 6 shows the fitting of gold electrodes on silicon wafer and copper PCB 
electrodes. A Warburg (Zw) is added in series with Rct in Figure 2 to represent the diffusion 
effect in EDL for a better fitting of the circuit at low frequency. Fitted values are listed in 
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Figure 4 Copper-based gold electroplated PCB electrodes by chemical etching. 
 
 
 
Figure 5 Gold Electrodes on silicon wafer. 
 
 
 
Figure 6 Equivalent circuit fitting of (a) gold electrodes on silicon wafer and (b) copper 
electrodes fabricated by printed circuit board (PCB) etching. 
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Table 1, from which it can be seen that for the gold electrodes on silicon wafer, Cs and Cint 
are comparable and both in nF level.  
At the experimental frequency, which is 100 kHz, the circuit is expected to be 
simplified into Cint in series with Rs only. In order to achieve that, XCint << XRct+Zw and XCs 
>> Rs are expected. From the calculated reactance values listed in Table 1, for gold 
electrodes on silicon wafer, XCs is not as greater than Rs as that of PCB copper electrodes. 
Therefore, as what has been justified by experiments, gold electrodes showed quite poor 
response that cannot correctly be associated with the occurrence of binding reactions. To 
satisfy XCint << XRct+Zw and XCs >> Rs, Cint is required to be much greater than Cs. Expression 
of Cint is given in Equation 3.4. Similarly, Cs is shown as follows: 
𝐶𝑠 = 𝐴𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒𝑠 [
1
𝜀𝑠
𝜋 (
𝑔
𝑠
+ 𝜎𝑤)]⁄                                                                                  (4.1) 
where Aelectrodes is the electrodes area, g and w are the electrodes digit gap and width 
separately, and σ, which is usually equal to 20%, is the percentage of the electrodes digit 
width that is included in Cs. The Cint/Cs ratio can then be estimated as follows by 
recalling Equation 3.4: 
𝐶𝑖𝑛𝑡
𝐶𝑠
=
𝐴𝑖𝑛𝑡 (
1
𝜀𝑝
𝑑𝑝+
1
𝜀𝑠
𝑑𝑒𝑑𝑙)⁄
𝐴𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑑𝑒𝑠 [
1
𝜀𝑠
𝜋(
𝑔
𝑠
+𝜎𝑤)]⁄
=
𝑤𝑙 (
1
𝜀𝑝
𝑑𝑝+
1
𝜀𝑠
𝑑𝑒𝑑𝑙)⁄
𝑤𝑙
2
[
1
𝜀𝑠
𝜋(
𝑔
2
+𝜎𝑤)]⁄
=
𝜋(𝑔+2𝜎𝑤)
𝑑𝑝+𝑑𝑒𝑑𝑙
> 103                               (4.2) 
where l is the electrodes digit length. Since the EDL thickness and bioparticle in real 
samples are both usually less than 100 nm, by using electrode in hundreds of micrometers 
would result in the Cint/Cs ratio to be as high as 10
3, which also offers explanation as to 
why gold electrodes on silicon wafer showed worse output response than the copper PCB 
electrodes.  
 
21 
Table 1 Equivalent circuit fitting for gold electrodes on silicon wafer and copper PCB 
electrodes (Reactance calculated at 100 kHz). 
Element 
Silicon Wafer 
[Gold] 
PCB 
[Copper] 
Rwire 5 Ω 8 Ω 
Rct 3400 Ω 36 Ω 
Zw 100 Ω∙S-0.5 1.3 MΩ∙S-0.5 
XRct+Zw(calculated) 3.4 kΩ 1.666 kΩ 
Cint 35 nF 20nF 
XCint(calculated) 45.47 Ω 79.57 Ω 
Rs 18 Ω 800 Ω 
Cs 3.3 nF 5.1 pF 
XCs(calculated) 482 Ω 0.31 MΩ 
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4.3 Electrodes surface treatments 
For the metal electrodes such as SAW chips and copper PCB electrodes, prior to 
incubation with linker and probe molecules, the microelectrode chips is thoroughly 
cleaned by washing with acetone, isopropyl alcohol and deionized water, and then treated 
with ozone or plasma. The surface quality is closely monitored by measuring the Cint. As 
for the laser printed electrodes, due to the multiscale morphology of the irradiated 
polyimide surface, wetting properties of interfacial capacitance sensors have become 
particularly important. The static contact angle of untreated polyimide is found to be 
79±1° (Figure 7(a)), consistent with previous reports[70]. After laser ablation, the contact 
angle is increased to 99±1° (Figure 7(b)). Based on the microstructure characterization, 
this hydrophobicity can be attributed to both the carbonization and porous surface 
structure.  
However, in most cases this hydrophobic character is not desirable for sensors, 
especially for detection in an aquatic medium. Plasma treatment is a good method for 
increasing the surface hydrophilicity by creating OH dangling bonds and enriching O- ions 
on the surface without influencing the electrode microstructure characteristics. After 10 
minutes of vacuum plasma treatment (PLASMA ETCH PE-50), the water drop completely 
infiltrates into the electrode surface (Figure 7(c)), indicating a marked surface transition 
from hydrophobicity to hydrophilicity. Besides plasma treatment, ozone treatment can also 
improve the hydrophilicity of the electrode surface by enriching O- ions on the surface. So 
three types of surface treatments are investigated, including ozone at 15 min, 30 min and 
plasma at 5 min.  
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Figure 7 A drop of deionized water (3 μL) on (a) pristine and (b) irradiated polyimide 
surfaces and (c) the irradiated polyimide surface after plasma treatment. (d) Electrodes 
with a mini-chamber and two Cu foil leads attached. (e) Sensor responses with different 
ozone surface treatments. 
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The ultimate criterion of surface treatment for biosensor is to obtain sensitive 
response. So BPA samples at concentrations of 0.1 fM, 1 fM and 10 fM are applied to the 
sensors. The sensor response for each treatment is shown in Figure 7(e). It can be seen that 
the plasma treated sensors consistently have higher response than ozone treated sensors, 
regardless of treatment time. This means that the immobilization efficiency of sensors 
treated with plasma is improved since more aptamer attached to the electrode surface made 
the surface less likely to become saturated (responses to 10 fM BPA showed significant 
difference between plasma and ozone treated sensors). In conclusion, the plasma treated 
sensor exhibits large responses even in the limit of high PBA concentration, yielding a 
combination of high sensitivity and large dynamic range. 
The electrode’s functionalization after plasma treatment includes receptor 
incubation and uncovered surface blocking. As the incubation and blocking processes 
progressed, an increasing number of molecules become attached to the electrode surface. 
The quality of electrode functionalization is monitored by measuring the Cint. This method 
is validated in our prior work [71]. During the incubation and blocking process, Cint values 
have reduced by -58.05±3.19% and -93.35±2.06% respectively for BPA, indicated 
adequate molecular immobilization on the electrode surface. Surface immobilization 
reduces the current flowing through the electrodes, effectively increasing the charge 
transfer resistance, Rct. Therefore Rct is also measured during the incubation and blocking, 
which showed an increasing Rct with time as shown in Figure 8. 
4.4 Measurements and data analysis 
This work uses ACEK-based capacitive sensing to monitor the molecular 
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Figure 8 Cyclic voltammetry characteristics of sensor’s (a) incubation and (b) blocking 
process. 
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deposition at the electrolyte/electrode interface. Prior work demonstrates that interfacial 
capacitance (Cint) can effectively detect molecular deposition on the electrode surface with 
high sensitivity and specificity[69],[72],[73]. In ACEK capacitive sensing, Cint is found by 
measuring the sensor cell’s impedance at a fixed AC frequency and voltage continuously 
during the testing. The interfacial capacitance of the electrodes is sampled and recorded 
periodically by an Agilent 4294A impedance analyzer for 20 seconds. Then the percentage 
change, dC/dt in %/min, of the measured capacitance is adopted as the readout of the sensor, 
indicating the binding reaction occurring on the electrodes surface. Least square linear 
fitting algorithm is performed to determine the capacitance change rate. 
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CHAPTER 5 
IMPROVEMENT AND OPTIMIZATION 
5.1 Cross linker for immobilization of protein probe 
5.1.1 Reagents and samples  
5.1.1.1 Protein IgG 
Sample solution uses 0.1×PBS (1 mM phosphate-buffered saline [pH 7.0] 
containing 15 mM sodium chloride) with a conductivity of 0.15–0.16 S/m (600–700 Ω∙cm) 
as standard buffer for sample diltuion. 1mg/mL KKKKKAAAC cross linker is prepared 
by adding 1.2 mg KKKKKAAAC cross linker (New England Peptide, Gardner, MA) into 
1.2 mL ultrapure water. The probe used for electrodes functionalization is 10 µg/mL bovine 
IgG whole molecule, which is 1:1000 dilution of 10 mg/mL bovine IgG whole molecule 
(Johnson ImmunoResearch, West Grove, PA) in ultrapure water. 1×101 to 1×106 fg/mL 
goat anti-bovine IgG antibody samples are obtained by diluting 2 mg/mL goat anti-bovine 
IgG antibody (Johnson ImmunoResearch) with 0.1×PBS. 100 µg/mL lactoalbumin is used 
for blocking, which is 1:10 dilution of 1mg/mL lactoalbumin (Sigma-Aldrich, St. Louis, 
MO) stock solution in ultrapure water. 4 µg/mL BSA, or bovine serum albumin protein, is 
prepared as interference by adding 40 µg BSA (Sigma-Aldrich, St. Louis, MO) in 10 mL 
0.1×PBS.  
5.1.1.2 Influnza A virus 
Sample solution in this work is prepared using the same 0.1×PBS and 0.1×PBS-T 
as described for protein detection tests. 0.1×buffer B is 0.1×PBS-T containing 10 v/v% 
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SuperBlock (Pierce Biotechnology, Rockford, IL) and is used as the blocking reagent. The 
chemical linker used for improving surface functionalization with antibody is 10 v/v% 3-
aminopropyltriethoxysilane (APTES, Thermo Scientific, Waltham, MA) in absolute 
ethanol and 2.5% glutaraldehyde in water. Antibody solution used for electrodes 
functionalization is 41.5 µg/mL anti-influenza A antibody in distilled water. 
Antibody for electrodes functionalization is 1:100 dilution of 4.15 mg/ml anti-
influenza A antibody (gift from a company) in distilled water to a concentration of 40 
µg/ml. Antibody for dummy electrodes is 40 µg/ml bovine IgG whole molecule (Code# 
001-000-003, Johnson ImmumoReserch, West Grove, PA), diluted from 10 mg/ml in 
distilled water. Spiked Influenza A virus sample is 1:100, 1:1,000 and 1:10,000 dilution of 
0.1525 mg/ml influenza A virus (a gift from a company) in 0.1×PBST to concentrations of 
1.525 µg/ml, 0.1552 µg/ml and 0.01525 µg/ml.  
5.1.2 Performance of sensors with cross linker modification 
As shown in Figure 9, 10 fg/mL, 100 fg/mL and 1 pg/mL goat anti-bovine IgG 
antibody spiked in 0.1×PBS are tested. Each concentration is tested in triplicate and their 
results are -3.07±0.59 %/min (10 fg/mL), -6.08±0.47 %/min (100 fg/mL) and -11.17±1.07 
%/min (1 pg/mL), while the responses of the buffer solution 0.1×PBS and non-specific 
interference 4 µg/uL BSA are -0.10±0.46 %/min and 0.099±0.44 %/min respectively. 
Dummy electrodes coated with 4 µg/uL BSA are also tested with 100 fg/mL and 1 ng/mL 
goat anti-bovine IgG antibody samples, which show very small responses (-0.47±0.71 
%/min and -1.13±0.46 %/min) compared with functionalized electrodes, indicating that the 
responses from active sensors are indeed due to the binding between the probe and the  
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Figure 9 Response of 0.1×PBS, 4µg/uL BSA and 10 fg/mL, 100 fg/mL and 1 pg/mL 
goat anti-bovine IgG antibody samples on electrodes functionalized with probe, in 
addition to 100 fg/mL and 1 ng/mL goat anti-bovine IgG antibody samples on dummy 
electrodes coated with BSA. Inset is dose response of sensor electrodes without APTES 
modification. 
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analyte. The dependence of dC/dt on analyte concentration is approximated by linear fitting 
as 𝑦 = −3.69654 ∙ lg𝑥 + 0.92916 where x is the analyte concentration in fg/μL and y is 
the capacitance change rate, d|C|/dt, in %/min. The LOD is defined as 3 standard deviations 
from the response of the background control. Because the background produced a response 
of -0.10±0.46 %/min, the cut-off d|C|/dt is calculated to be -1.49 %/min, which corresponds 
to 4.513 fg/mL goat anti-bovine IgG antibody. Dose response of electrodes without APTES 
modification is investigated in previous work[73], and  it is shown in the inset of Figure 9. 
The responses are quite small and the data points are in ‰/min instead. In the tests with 
electrodes functionalized with passive adsorption of probe protein, the IgG antibody 
concentration ranges from 0.2 ng/mL to 10 ng/mL, and the tests of every IgG antibody 
concentration are also repeated three times using a new electrode each time. The responses 
for IgG antibody samples are -0.02±0.13 ‰/min at 0.2 ng/mL, -3.07±0.38 ‰/min at 0.5 
ng/mL, -5.09±0.38 ‰/min at 1 ng/mL, and -6.93±0.56 ‰/min at 2 ng/mL respectively. 
Using an AC signal of 1 Vrms AC voltage with a duration of 10 min, an LOD of around 1 
ng/mL is reached. 
Dose response of influenza A virus samples in various concentrations (15.25 
pg/mL, 152.5 pg/mL, 1.525 ng/mL, 15.25 ng/mL and 152.5 ng/mL) is shown in Figure 10. 
Tests are firstly conducted on the electrodes functionalized with bioreceptors by passive 
adsorption (i.e. without chemical linkers between electrodes and bioreceptors) and the 
results (blue data points) demonstrate very low outputs from the sensor (-0.5124±0.2101 
%/min, -0.7529±0.1813 %/min, -0.7451±0.3147 %/min, -0.8126±0.4214 %/min for 0.1525 
ng/mL, 1.525 ng/mL, 15.25 ng/mL and 152.5 ng/mL influenza A virus in 0.1×PBST  
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Figure 10 Dose response of influenza A samples as a function of concentration. Tests 
conducted on electrodes modified with APTES chemical linker (black) yields a linear 
correlation between sensor output and sample concentrations with an LOD of 0.2513 
pg/mL. Tests conducted on electrodes treated with passive functionalization method 
(blue) demonstrates very small responses.  
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respectively). In contrast, the sensor’s responses are significantly improved by modifying 
electrodes with APTES before bioreceptors immobilization. Shown as the red data points 
in Figure 10, the averaged responses of dC/dt are -2.72±0.34 %/min for 15.25 pg/mL virus 
sample, -3.67±0.37 %/min for 152.5 pg/mL, -5.06±0.29 %/min for 1.525 ng/mL, -
6.46±0.64 %/min for 15.25 ng/mL and -7.59±0.46 %/min for 15.25 ng/mL. Reponses of 
control tests and dummy electrodes are 0.18±0.19 %/min and 0.73±0.23 %/min 
respectively, which can be easily differentiated from the responses of functionalized 
electrodes. The dose response can be fitted by Equation 4.1 with a correlation coefficient 
(R2) of 0.994.  
𝑑𝐶
𝑑𝑡
(%/min ) = −1.236 ∙ lg (𝑥 (ng/mL)) − 4.855     (4.1) 
where x is sample concentration in ng/mL. 
LOD is defined as three times the standard deviations (0.5816 %/min) from the 
background response, which is 0.1×PBS-T (0.1769 %/min). The LOD, also the threshold 
value for differentiating the positive samples from the negative, is calculated to be -0.4048 
%/min which corresponds to 0.2513 pg/mL influenza A virus. 
5.2 Immobilization buffers 
5.2.1 Reagents and samples 
5.2.1.1 Zika RNA Washing buffer and blocking reagent 
0.5×SSC buffer is prepared by 1:40 dilution of AccuGENE™ 20×SSC Buffer 
(Lonza, Rockland, ME USA) in ultrapure water. Blocking solution is 1.0 mM 6-
mercaptohexanol (Sigma-Aldrich, St. Louis, MO) prepared in ultrapure water. A 5’-thiol-
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modified oligo probes, 5’-TTTCGCTCTATTCTCATCAGTTTCATGTCCTGTGTC-3’, 
is synthesized by Fisher Thermo, which is then suspended in DNase/RNase free water to 
reach a concentration of 100 μM. The probe has a 100% match with Zika virus American 
Strain with a target region of 1373-1408. It has 26 out of 36 nucleotides matches Zika 
Uganda strain (targeting Uganda region 1433-1462). DNA probes are diluted to 20 μM in 
0.05×PBS.  
5.2.1.2 Human herpes virus-1 dsDNA 
Testing buffer is based on 20× saline-sodium citrate (SSC) buffer and then diluted 
to make 2×, 1× and 0.5×SSC in ultrapure water. 5’ thiol-modified human herpesvirus 1 
probe (HSV-1, 5’- CAAGGCTCACGTGCGAGAGAGCCTCCTC -3’)[74] is designed to 
specifically target UL30 gene of HSV-1, which is then prepared in DNAse/RNAse free 
water at a concentration of 20 μM. Genomic dsDNAs of Human herpesvirus 1 (HSV-1, 
Strain McIntyre, ATCC® VR-539D, ATCC, Manassas, VA) and Human herpesvirus 2 
(HSV-2, Strain G, ATCC® VR-734, ATCC, Manassas, VA) are prepared in ultrapure 
water at concentration of 36 μg/mL and 1.3 μg/mL respectively, as stock sample solution. 
5.2.2 Sensor performance with various immobilization buffers 
Various immobilization buffers (buffers that probe are diluted in for electrodes 
functionalization) and testing buffers (buffers that target nucleic acid are diluted in for 
detection) can lead to various sensor performances[75]. Therefore, multiple tests of Zika 
virus RNA and HSV-1 DNA detections are conducted to define the roles these buffers play 
in detections. In Figure 11, tests of 18.76×103 copies/μL Zika virus RNA sample are 
conducted on chips with probes prepared in different buffers which would affect the  
 
34 
 
Figure 11 Tests of 18.76×103 copies/μL Zika virus RNA sample are conducted on chips 
incubated with probes prepared in ultrapure water, 0.05×PBS and 1×PBS. Probes in 
0.05×PBS is considered to be the optimal due to its high response.  
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electrodes surface functionalization. Ions in the buffer screen the electrical charges of 
nuclei acids and allow for higher coverage of electrode surface during immobilization. 
However, too much ions will cause nuclei acids to coil and lose the ability to bind with 
other molecules. Buffers of various ionic strengths, including ultrapure water, 0.05×PBS 
and 1×PBS, is used to functionalized the sensors, and the resultant sensors yield responses 
of 6.09±0.70 %/min, 7.52±0.78 %/min and 3.02±1.83 %/min, respectively. Clearly, probe 
in 0.05×PBS leads to the highest response and therefore is used as the optimal 
immobilization buffer in subsequent experiments. 
Further, dose responses of HSV-1 DNA probe in water and 0.05×PBS are obtained 
and demonstrated in Figure 12. With HSV-1 DNA sample diluted in 0.5×SSC, utilizing 
0.05×PBS as buffer for probe incubation (black) gives sensor better performance than 
ultrapure water (blue). This is because, compared to ultrapure water, 0.05×PBS contains 
more ions and is able to screen the electrical charges of nuclei acids. It can facilitate probe’s 
immobilization on the surface by allowing for higher coverage of electrodes surface during 
immobilization. 
5.3 Testing buffers 
Next, for the testing buffers, similarly, Zika virus RNA and HSV-1 DNA are also 
utilized for testing. Three concentrations of Zika virus RNA from 187.6 copies/μL (1.0 
pg/mL) to 18,760 copies/μL (100 pg/mL) are tested in triplicate with a new functionalized 
sensor each time. Three concentrations are spiked in 0.5×SSC and 1×SSC solution 
respectively and tested three times using prepared sensors. Their d|C|/dt responses and 
standard deviations are shown in Figure 13. The three samples are clearly differentiable 
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Figure 12 Evaluation of sensor’s performances when probe is prepared in 0.05×PBS and 
ultrapure water. Probe prepared in 0.05×PBS and DNA samples in 0.5×SSC (black) is the 
optimal immobilization buffer with an LOD of 0.986 pg/mL (6.38 copies/μL or 0.0106 
fM). 
 
 
Figure 13 Dose response of Zika RNA spiked in 0.5×SSC and 1×SSC for testing buffer 
evalution. 0.5×SSC is considered to be the optimal testing buffer and d|C|/dt is 2.40±0.50 
%/min for 187.6 copies/μL (1 pg/mL), 5.19±1.12 %/min for 1,876 copies/μL (10 pg/mL) 
and 7.52±0.78 %/min for 18,760 copies/μL (100 pg/mL), showing a clear logarithmic 
dependence on Zika virus RNA. Its LOD in 0.5×SSC is yielded to be 0.986 pg/mL 
(78.825 copies/μL) with a response of 1.458 %/min. 
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from the background, and their response has a logarithm dependence on concentrations. 
However, by comparing the slopes of these two curves, target RNA prepared in 0.5× SSC 
reveals it superiority to the target in 1×SSC. For tests with Zika virus RNA in 0.5× SSC as 
testing buffer, d|C|/dt is 2.40±0.50 %/min for 187.6 copies/μL (1.0 pg/mL), 5.19±1.12 
%/min for 1,876 copies/μL (10 pg/mL) and 7.52±0.78 %/min for 18,760 copies/μL (100 
pg/mL). The dependence of d|C|/dt on Zika virus RNA concentration can be approximated 
fitted as 𝑦 = 2.56978 ∙ lg𝑥 − 3.41633, where x is the Zika virus RNA concentration in 
copies/μL and y is the capacitance change rate, d|C|/dt, in %/min. The LOD is 78.825 
copies/μL, or 0.4222 pg/mL, which is defined as 3 standard deviations from the response 
of background control (0.53±0.31 %/min). The corresponding cut-off d|C|/dt is calculated 
to be 1.458 %/min. 
In a separate experiment, Dengue virus type 2 RNA (New Guinea strain) of 1 ng/ml 
(190,850 copies/μL) is suspended in both 0.5×SSC and 1×SSC and tested as interference, 
yielding responses of 3.02±0.35 %/min and 4.78±0.80 %/min respectively. So, given the 
performances on sensitivity and specificity, 0.5×SSC is used as the optimal testing buffer 
for Zika virus RNA sample dilution. 
As for testing HSV-1 DNA in different testing buffers, as shown in Figure 14, either 
with 0.05×PBS or ultrapure water for electrodes’ functionalization, DNA samples diluted 
in 0.5×SSC always show higher responses than those in 2× SSC or 1× SSC. It is easy to 
conclude that buffer used for DNA sample dilution with a relatively low conductivity yields 
high responses. This is because that relatively low fluid conductivity can result in strong  
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Figure 14 Evaluation of sensor’s performances when HSV-1 virus DNA is prepared in 
0.5×, 1× and 2×SSC. Probe prepared in 0.05×PBS and DNA samples in 0.5×SSC (black) 
is the optimal immobilization buffer with an LOD of 0.986 pg/mL (6.38 copies/μL or 
0.0106 fM). 
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DEP effect. In Equation 3.1, lower fluid conductivity gives greater Clausius–Mossotti 
factor value. Thus, bioparticles in low fluid conductivity will have high DEP velocity.  
Based on the given results in Figure 14, HSV-1 probe in 0.05×PBS and HSV-1 
DNA (target), HSV-2 (interference) in 0.5×SSC are considered to be optimal with 
responses of -3.90±0.52 %/min (9 pg/mL), -6.92±0.94 %/min (90 pg/mL) and -9.72±0.63 
%/min (900 pg/mL). The sensor’s LOD is defined as 3 standard deviations from the 
response of the background control (-0.22±0.30 %/min), so the cut-off d|C|/dt is calculated 
to be -1.12 %/min, which corresponds to a HSV-1 DNA concentration of 0.986 pg/mL 
(6.38 copies/μL or 0.0106 fM). Tests of interference (HSV-2 DNA) also demonstrate a 
good specificity with a low response of -0.19±0.60 %/min at a concentration (5 ng/mL) 
550 times higher than that of HSV-1. 
5.4 Applied AC signal frequency and voltage 
To elucidate the effects of ACEK mechanisms on detection, the first set of 
experiments is to find out the effect of AC frequency on the sensor response. Based on 
Equation 3.1, DEP effects are frequency-dependent. AC signals of various frequencies at 
10 mV are used to measure the capacitance changes from influenza A virus samples at a 
concentration of 1.525 ng/mL. The measured capacitance change rates are given in Figure 
15(a). The response shows a bell-shape dependence on AC frequency, with its optimal 
frequency between 50 kHz and 100 kHz, which indicates that the DEP is the dominant 
enrichment mechanism. Consequently, AC signal at 100 kHz is considered as the 
optimized frequency.  
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Figure 15 Responses of 0.1×PBS-T, 1.52 ng/mL influenza A virus on functionalized 
electrodes, and 152.5 ng/mL influenza A virus sample on dummy electrodes (a) when 
using 10 mV AC signal with its frequency varied from 20 kHz to 200 kHz and (b)when 
using 100 kHz AC signal with its voltage varied from 5 mV to 100 mV. (c) Responses of 
50, 500 and 5000 pg/mL HSV-1 virus DNA and 5000 pg/mL HSV-2 virus DNA. 
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Next, AC voltages varying from 5 mV to 100 V are used to measure 1.52 ng/mL 
influenza A virus sample on functionalized electrodes. The background blank buffer, which 
is 0.1×PBS-T, is also tested on the functionalized electrodes from 5 mV to 100 V as control. 
Negative control experiments with 152.5 ng/mL influenza A virus sample are measured 
under the same voltage conditions on dummy electrodes (electrodes without antibody). 
Experiments with each voltage are repeated three times.  
As shown in Figure 15(b), responses of the 0.1×PBS-T control samples on 
functionalized electrodes and 152.5 ng/mL influenza A virus sample on dummy electrodes 
remain quite small through the voltage range of 5-100 mV, with a limited response ranged 
from -0.14 to -0.24 %/min and 1.02 to -0.01 %/min. For tests on functionalized electrodes, 
due to DEP effect, the capacitive response decreases as the voltage increases from 5 to 100 
mV, indicating that more binding takes place with higher AC voltage. When the voltage 
level is above 10 mV, the increase of sensor’s response becomes limited due to saturation 
of binding sites on the sensor. Therefore, 10 mV is chosen as the measuring voltage. At 
this voltage, DEP effect will be weak for particles smaller than virus such as protein to 
cause appreciable capacitance change[69], therefore improved the sensor specificity in 
complex matrix. This can also be justified by the tests of HSV-1 virus DNA conducted 
under 10 mV and 25 mV in Figure 15(c). While the sensor yields higher outputs at 25 mV, 
the sensor also shows non-negligible responses (-1.87±0.43 %/min) to 5 ng/mL HSV-2 
DNA. In contrast, the response of 5 ng/mL HSV-2 DNA is 1.21±0.31 %/min at 10 mV, 
which is considered to a negative response as it cannot be differentiated from that of the 
background. A good sensor requires the sensor to have large responses to target molecules 
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with little to none responses non-targets. Test results of HSV-1 and HSV-2 indicate that 
using AC signal at 10 mV can achieve good specificity with only slight compromise on 
response (dC/dt values). Therefore, 10 mV is also considered to be superior to 25 mV in 
detection of HSV-1 virus DNA. 
5.5 Summary of the sensing platform’s performances 
For the four different pathogen targets in standard matrices studied previously, 
Table 2 summarizes their assay time, LODs, and matrices in which the LODs are obtained. 
The performances of the biosensing platform in this work are significantly improved. It 
can detect specific targets within 30 seconds, with quite low LODs in pg/mL or fg/mL 
levels. The sensor also demonstrates good specificity against other interferences, which 
make it has a great potential to be used for testing in complex sample matrices.  
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Table 2 Summary of the sensing platform’s performance on detecting various 
pathogens. 
Target Matrix LOD Assay time 
influenza A virus 0.1×PBS-T 0.25 pg/mL 30 seconds 
protein IgG/pseudorabies 0.1×PBS 4.5 fg/mL 30 seconds 
DNA/Human herpesvirus 1 0.5×SSC 0.986 pg/mL 30 seconds 
RNA/Zika 0.5×SSC 1 pg/mL 30 seconds 
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CHAPTER 6 
VARIOUS APPROACHES FOR PATHOGENS DETECTION IN 
COMPLEX MATRICES 
6.1 Influenza A virus 
Clinical nasal swab Influenza A virus sample with nasal swab is immersed in 
M4RT[76] are provide by a company and a serial dilution up to 1:10000 is applied using 
0.1×PBST. It is common practice to dilute clinical samples in standard buffer. Due to the 
complexity of clinical samples, highly diluted samples can reduce non-specific binding, 
which improve the selectivity of the sensor. With more dilution of clinical samples, chances 
of false positive results can be reduced. However, sensor’s sensitivity will also suffer since 
the concentration of target particles is reduced at the same time. The optimization dilution 
factor helps to decide which dilution can be used for the bind tests of unknown swab 
samples in the next step. In addition, unlike the spiked samples in previous sections, clinical 
swab samples are in M4RT instead of 0.1×PBS-T. M4RT is a liquid medium commonly 
used in the transport of clinical specimens to the laboratory for qualitative microbiological 
procedures for viral and chlamydial agents. M4RT with no dilution can cause a decrease 
in capacitance (-0.48±0.035 %/min), but for M4RT with 1:1,000 dilution or more in 
0.1×PBS-T its effect can be neglected (0.46±0.45 %/min at 1:1000 dilution). So dilution 
factors higher than 1:1000 are studied in Figure 16. To find out the optimal dilution factor 
to test, two clinical nasal swab samples (one positive and one negative) at various dilution 
factors from 1:100,000 to 1:1,000. Each sample is tested in triplicates, and each chip is  
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Figure 16 Responses of clinical negative and positive swab samples of dilution factor of 
1:100,000, 1:10,000 and 1:1,000. 
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tested with three dilutions in the sequence of 1:100,000, 1:10,000 and 1:1,000. Based on 
the sensor’s readout in Figure 16, response reaches the highest at 1:10,000 dilution of 
positive sample. The 1:1000 dilution did not yield a larger response due to the saturation 
of the limited available binding sites on the electrode’s surface. Nevertheless, 1:100,000 
dilution is adopted instead of 1:10,000 since the response of sample at 1:100,000 dilution 
(-4.09±2.06 %/min) is located around the median of the dose response line shown in Figure 
10. So 1:100,000 dilution is chosen in order to acquire a larger dynamic range in sensor 
response, desirable for clinical swab samples measurement in blind tests. 
Blind tests for a panel of 20 nasal swab samples (10 positive, 10 negative) are 
conducted. All samples are 1:100,000 diluted with 0.1× PBS-T. The threshold value is set 
at -0.40 %/min, which is also the LOD from previous tests with spiked samples, meaning 
that samples with a response more negative than -0.40 %/min will be considered as positive 
samples and others negative. As shown in Figure 17(a), 9 out of 10 positive and 7 out of 
10 negative samples are correctly identified by ACEK capacitive sensors. A negative 
sample with influenza B virus is also correctly identified. All these samples are verified by 
RT-qPCR, yielding a sensitivity of 90% and specificity of 70% for the panel. Figure 17(b) 
shows a positive correlation between the capacitance change rate and PCR cycles number. 
Weak positive samples are chosen for this set of experiments. Among all the detected 
positive samples, only the sample with the highest response can be detected by a 
commercial RIDT, which corresponds to 22 PCR cycles. ACEK capacitive sensor can 
detect virus level corresponding to 35 PCR cycles. There is a false negative corresponding 
to 29 PCR cycles. This is possibly due to error during dilution or the binding site on the  
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Figure 17 Comparison of results from ACEK capacitive sensors and those from 
commercial tests for a blind panel test of influenza virus A from nasal swabs. (a) 
Responses of all tested samples differentiated by the -0.40 %⋅min-1 cut-off line (blue) and 
(b) correlation between PCR cycles and responses of samples determined as positive by 
ACEK capacitive sensor in blind tests. The strongest positive sample is the limit of a 
commercial rapid influenza test.  
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virus not being exposed.  
6.2 Protein (antibody to pseudorabies virus) 
Serum spiked goat anti-bovine IgG antibody samples are tested to demonstrate the 
sensor’s performance in complex matrix. HyClone™ Fetal Bovine Serum (U.S.), Standard 
(FBS) is purchased from Fisher Scientific, Waltham, MA. It is then 1:10 and 1:100 diluted 
in 0.1×PBS-T to obtain 1:10 and 1:100 FBS solution respectively for preparing of goat 
anti-bovine IgG serum spiked samples. In order to gauge the effect of FBS matrix at various 
frequency, 1:10 and 1:100 FBS are tested under the applied AC signal ranges from 20 kHz 
to 200 kHz in Figure 18(a). The sensor response is found to decrease with increasing 
frequency for both 1:10 and 1:100 FBS. However, 1:100 FBS demonstrate essentially 
lower responses than 1:10 FBS. Therefore, dose response of protein in serum matrix is 
studied by spiking goat anti-bovine IgG into 1:100 FBS at concentrations of 10, 100 and 
1000 fg/mL in Figure 18(b). 
Next, pseudorabies virus clinical samples, three positive and three negative, are 
tested. The swab samples are diluted 1:10,000 v/v% in 0.1×PBS-T solution, which. 
contains 0.05 v/v% Tween 20 (Fisher Scientific, Pittsburgh, PA), Positive samples can be 
clearly differentiated from negative samples in Figure 19. 
6.3 Nucleic acids RNA and DNA 
6.3.1 Reagents 
Human blood samples are collected from pregnant women who entered labor and  
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Figure 18 (a) Responses of FBS in different dilution rates. (b) Dose response of protein 
IgG in 1% serum matrix.  
 
 
 
Figure 19 Tests of pseudorabies virus clinical samples. Positive and negative samples 
can be clearly differenced. 
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delivery at the University of Tennessee Medical Center, Knoxville. All samples andclinical 
information are collected under clinical research protocols approved by the University of 
Tennessee Institutional Review Boards. These human blood samples are centrifuged at 
2,000 rpm for 15 minutes and sera are pooled. After being diluted 1:100 in 0.1×PBS, the 
obtained 1% serum sample is then 1:1 mixed with lysing solution, which contains 1 mM 
Tris (pH 8.0), 2 mM EDTA, 1% SDS and 2 mg/mL Proteinase K (Fisher BioReagents, 
Pittsburgh, PA).  
Quantitative genomic RNA from Zika virus is purchased from ATCC (ATCC® 
VR-1838DQ, ATCC, Manassas, VA) and diluted in serum/lysing solution to 0.1876×103 
copies/μL (1.0 pg/mL), 1.876×103 copies/μL (10 pg/mL), 18.76×103 copies/μL (100 
pg/mL), 187.6×103 copies/μL (1 ng/mL) and 1876×103 copies/μL (10 ng/mL), 
respectively. Quantitative genomic DNA from human herpesvirus 1 (HSV-1) (ATCC® 
VR-539DQ™, ATCC Manassas, VA) is diluted in serum/lysing solution for a 
concentration of 6.585×103 copies/µL (1 ng/mL). Dengue virus type 2 (New Guinea strain) 
is diluted in serum/lysing solution to 19,095 copies/µL (0.1 ng/mL) respectively. Influenza 
A virus (gift from a company) is suspended in serum/lysing solution to 1.525 ng/mL 
6.3.1 Zika virus RNA 
Five concentrations of Zika virus RNA are spiked in 1:1 mixture of 1% serum and 
lysing solution, and tested using functionalized sensors. Each concentration is tested in 
triplicates with a new chip each time. Like the samples spiked in 0.5×SSC, five Zika virus 
RNA spiked serum samples are clearly differentiated from each other and the background. 
As shown in Figure 20, d|C|/dt is 2.04±0.22 %/min for 0.1876×103 copies/μL (1.0 pg/mL),  
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Figure 20 Responses of non-specific nuclei acid (HSV-1 and dengue) and virus 
(influenza A), and dose response of Zika virus RNA spiked in serum/lysing solution. 
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gradually increasing to 7.77±0.45 %/min for 1,876×103 copies/μL (10 ng/mL) RNA. 
d|C|/dt shows a clear logarithmic dependence on Zika virus RNA concentration over at 
least four orders of magnitude from 1.0 pg/mL to 10 ng/mL. The dependence of d|C|/dt on 
Zika virus RNA concentration can be approximated as y=1.99369∙lgx-2.59808, where x is 
Zika virus RNA concentration in copies/μL and y is capacitance change rate, d|C|/dt, 
in %/min. The fitted line had a correlation coefficient of 0.97, and is used as the sensor 
standard curve. The LOD is defined as 3 standard deviations from the response of the 
background control. Because the background produced a response of -0.39±0.72 %/min, 
the cut-off d|C|/dt is calculated to be 1.786 %/min, which corresponded to a Zika virus 
RNA concentration of 158.1 copies/μL, or 0.846 pg/mL. The LOD of Zika virus RNA in 
serum is slightly higher than that of RNA in SSC (78.8 copies/μL), which is expected due 
to more interference molecules in serum. To exclude possible artifacts as causes of sensor 
response, control tests are conducted by applying Zika virus RNA samples of the same 
concentrations on dummy electrodes (without functionalization, and only blocked with 1.0 
mM 6-mercaptohexanol in ultrapure water). As shown in Figure 20, the responses from the 
dummy electrodes are negligible, at -0.092±0.12 %/min, -0.23±0.43 %/min, 
0.38±0.39 %/min, 0.35±0.13 %/min and 0.51±0.12 %/min respectively, which are very 
similar to the response of fluid background. This indicates that the responses from active 
sensors are indeed caused by the hybridization between the probe and the target RNA. 
In Figure 21, with the same lysing solution containing 1% serum, sensors 
functionalized with three different probes are tested and compared. The probe used 
previously in Chapter 5 is denoted as Probe #0. Probe #1 has a sequence of  
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Figure 21 Responses of Zika virus RNA in lysing or GuSCN solution containing 1% 
serum by various probes.  
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TCTTCAGCCTCCATGTGTCATTCTTTTCACTTTCAA, and Probe #2 has a sequence 
of TTTCGCTCTATCTTCGTCAGTTTCATATCCAATCAT. Probe #1 and #2 both have 
a 100% match with Zika virus Uganda Strain, with target genomic sequence regions of 
3116-3081 and 1427-1462 of Zika virus (strain MR 776, GenBank: AY632535.2)[77]. 
Although responses by sensors functionalized with Probes #1 and #2 show higher 
sensitivity than those with Probe #0, Probe #2 demonstrates a much higher sensor readouts. 
By comparing results of target RNA prepared in 1% serum/lysing and 1% serum/GuSCN, 
it can be concluded that diluting Zika RNA into testing buffer containing GuSCN solution 
(green) does not make any improvement over that into lysing solution (blue). This might 
be due to the high conductivity that GuSCN has. At sensor’s working frequency of 100 
kHz, the equivalent circuit of the sensor electrodes can be simplified as bulk solution 
resistance Rs in serial with interfacial capacitance Cint. The bulk solution resistance is 3.28 
kΩ and 84.1 Ω in 1:1 mixture of 1% serum/lysing solution and 1:1 mixture of 1% 
serum/GuSCN solution respectively. The impedance of interfacial capacitance is 
calculated to be 564.9 Ω in 1% serum/lysing solution and 39.9 Ω in 1% serum/GuSCN 
solution. Consequently, 85.32% of the total applied AC signal (~8.53 mV) is applied over 
the bulk 1% serum/lysing solution and 67.78% (~6.78 mV) over the bulk 1% 
serum/GuSCN solution. Therefore, with buffer in lower conductivity, more electric field is 
applied and utilized to induce DEP for bioparticle enrichment. 
Next, sensor’s specificity is evaluated by using Dengue virus RNA as interference. 
Probe # 1 and # 2 are used for sensor electrodes functionalization and both Zika virus RNA 
(target) and Dengue virus RNA (interference) are spiked into 1:1 mixture of serum and 
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lysing solution. Given 2×SSC solution’s aid in RNA target-probe hybridization, 2×SSC is 
adopted to make 1:1:1 mixture of serum, GuSCN and 2×SSC to improve the performance 
of testing buffer containing GuSCN solution used in previous assay (green curve in Figure 
21). Therefore, Zika and Dengue virus RNA are also spiked into 1:1:1 mixture of serum, 
GuSCN and 2×SSC to find out the optimal combination of probe and testing buffer which 
would offer both excellent sensor sensitivity, readouts, as well as specificity. In figure 22(a) 
and 23(b), for Probe #1, tests of Dengue virus RNA utilizing 1:1:1 mixture of serum, 
GuSCN and 2×SSC as testing solution demonstrates both lower responses and curve slope, 
meaning 1:1:1 mixture of serum, GuSCN and 2×SSC as testing solution shows superiority 
in sensor’s specificity. The similar results are also observed in tests with Probe #2 (Figure 
22(c) and 22(d)). In addition, by adding 2×SSC, sensor also yields higher response 
compared with responses from previous GuSCN solution. Thus, if comparisons are made 
between Figure 22(a)(c) and Figure 22(c)(d), it can be easily concluded that sensor yields 
the optimal performances on sensitivity and specificity with electrodes functionalized with 
Probe #2 and target Zika RNA (interference Dengue virus RNA) in 1:1:1 mixture of serum, 
GuSCN and 2×SSC as testing solution.  
In Figure 23, the percentage rate of serum in the optimized testing buffer is adjusted 
from 33% to 50% (from 1:1:1 mixture to 2:1:1). In order to be able to evaluate the effect 
this adjustment will have on the sensor’s performance, the Zika virus RNA concentration 
is converted into the equivalent concentration in pure serum.For the adjusted testing buffer 
of 2:1:1 mixture, sensor indicates a less sensitive dose response with 2.29±0.20 %/min for 
0.3752×103 copies/μL, 5.23±0.46 %/min for 3.752×103 copies/μL and 9.08±1.07 %/min  
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Figure 22 Zika and Dengue virus RNA responses with various probes (Probe #1 and #2) 
and testing buffer containing pure serum: (a) Probe #1 with 1:1:1 of serum, GuSCN and 
2×SSC as testing buffer; (b) Probe #1 with 1:1 of serum and lysing solution as testing 
buffer; (c) Probe #2 with 1:1:1 of serum, GuSCN and 2×SSC as testing buffer; and (d) 
Probe #2 with 1:1 of serum and lysing solution as testing buffer. 
 
 
Figure 23 Responses of tests on Probe #2 functionalized electrodes vs. Zika virus RNA 
concentration converted into pure serum. 
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for 37.52×103 copies/μL.While for 1:1:1 mixture, 0.5628×103 copies/μL, 5.628×103 
copies/μL and 56.28×103 copies/μL Zika virus RNA in pure serum have responses of 
2.62±0.64 %/min, 6.33±0.67 %/min and 10.92±0.66 %/min respectively.  
6.3.3 HSV-1 DNA 
In order to avoid the protein sediment in serum when samples are heated to 95 °C 
for DNA denaturation, DNA serum spiked samples are diluted into lysing solution. Lysing 
solution can break down peptide bonds, digest proteins in serum and help reduce sediment 
that may affect DNA hybridization during tests. In Figure 24, 900 pg/mL HSV-1 DNA in 
undiluted serum is 1:2, 1:2.5, 1:3.3, 1:5, 1:10 and 1:20 diluted into lysing solution 
respectively before denaturation (actual concentration in serum is 450 pg/mL, 360 pg/mL, 
270 pg/mL, 180 pg/mL, 90 pg/mL and 45 pg/mL). For dilution factor ranged from 1:2 to 
1:20, sensors’ responses are 0.50±0.19 %/min, -1.38±0.55 %/min, -2.46±0.15 %/min, -
3.437±0.28 %/min, -5.64±0.59 %/min and -6.34±0.49 %/min with a background response 
of -0.38±0.20 %/min. It can be concluded that serum spiked samples with more dilution 
will yield higher d|C|/dt responses. 1:20 and 1:10 in Figure 24 shows the highest yet 
comparable responses. Therefore, dilution factors of 1:20 and 1:10 are used in the 
subsequent experiments of HSV-1 DNA spiked serum samples. 
Figure 25 demonstrates the logarithmic dependence of HSV-1 DNA concentrations 
on sensor response (d|C|/dt in %/min). The shown HSV-1 DNA concentrations are 
concentrations in neat serum, which are 90 pg/mL, 900 pg/mL and 9 ng/mL. Two dilution 
factors of 1:20 and 1:10 show similar performances in Figure 25. The LOD are calculated 
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Figure 24 Responses of DNA spiked serum diluted in lysing solution using different 
dilution factors. 
 
 
Figure 25 Dose response of HSV-1 DNA serum samples with 1:20 and 1:10 dilution. 
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to be 19.46 pg/mL (125.98 copies/μL or 0.21 fM) and 29.73 pg/mL (192.46 copies/μL or 
0.32 fM) for 1:20 and 1:10 dilution respectively. Since samples with 1:20 dilution show 
slight advantages on sensitivity, LOD and sensor readouts, it is considered to be the optimal 
dilution factor for HSV-1 DNA spiked serum sample tests.  
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CHAPTER 7 
EXPANSION TO CHEMICAL DETECTION 
Reproduced in part with permission from Bisphenol A Sensors on Polyimide 
Fabricated by Laser Direct Writing for Onsite River Water Monitoring at Attomolar 
Concentration, Cheng Cheng, Shutong Wang, Jayne Wu, Yongchao Yu, Ruozhou Li, 
Shigetoshi Eda, Jiangang Chen, Guoying Feng, Benjamin Lawrie, and Anming Hu, ACS 
Applied Materials & Interfaces 2016 8 (28), 17784-17792, DOI: 10.1021/acsami.6b03743. 
Copyright 2016 American Chemical Society. 
In recent years, there is an increasing interest in developing effective tools for 
bisphenol A (BPA) detection in the environment and food supply. Different from the 
protein, virus or nucleic acids in size, BPA is small molecule and a different ac 
electrokinetics mechanism, ac electroosmotic (ACEO) effect, is used for more effective 
transport of the target analyte in water. In this work, ACEO-based capacitive sensing is 
used to detect the binding of BPA with aptamer at the electrode surface. In additional, to 
further reduce the sensor cost and improve the LOD for water monitoring, laser printed 
electrodes on polyimide are adopted as the sensor in this work. 
7.1 Electrodes fabrication 
The laser written electrodes used in this work are fabricated by a femtosecond (fs) 
pulsed laser (Cazadero, Calmar Laser Inc.) and a 532 nm CW laser (Verdi G5, Coherent) 
via a 20 × microscope objective (NA=0.42) on the flexible Polyimide (PI) sheet 
(Kapton_HN, 100 µm thickness) (Figure 26(a)). The fs laser generates pulses with 1030  
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Figure 26 (a) Schematic illustration of the laser direct writing of electrode on a 
polyimide substrate, (b) Typical photo image of flexible electrodes, (c) SEM images of 
the porous carbonized structures and (d) Raman spectra of the polyimide regimes with 
and without laser irradiation. 
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nm central wavelength, and 400 fs pulse duration at a repetition rate of 120 kHz. The PI 
films are mounted on an XY-translation stage controlled by a computer. In our case, the fs 
laser and CW laser power concentrated on the sample surface are 230 mW and 85 mW 
with a spot size of 3-5 μm, respectively, and a scanning speed of 0.5 mm/s. All irradiation 
is performed in air environment under normal incidence. The gap distance between 
adjacent finger electrodes is fixed at 90 μm, and a total of 8 pairs of electrode fingers are 
written in one sensor (Figure 26(b)). The generation of black lines on the polyimide sheet 
after the laser scanning confirmed the carbonization of the polymer. Figure 26(c) illustrates 
the porous flake structures of the irradiated regimes. This porosity is a result of polyimide 
molecules initially dissociating in the vicinity of focal point of the fs laser as a result of 
multi-photon absorption[78]–[80]. Raman spectra shown in Figure 26(d) indicates the 
recorded at three areas under excitation at 532 nm: (1) near the center of the carbonized 
electrode, (2) about 40 µm away from the center, and (3) at the unexposed PI film. 
Prior to irradiation, the PI film is cleaned using ethanol. Finally, the surface 
morphology is observed using optical microscopy and scanning electronic microscopy 
(Zeiss Auriga). After surface treatment by plasma cleaner or ozone cleaner, a 
microchamber is attached to the foil surface for surface functionalization and subsequent 
sensing. 
Appropriate working frequency is also vital in this work and can be found and 
estimated by the equivalent circuit cell fitting. For example, an optimal frequency at which 
ACEO flow velocity peaks for a given AC voltage needs to be selected in the BPA 
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detection. Referring to Equation 3.2, 𝐸𝑡 is dependent on the bulk impedance (Rs and Cs) 
and 𝛥𝜉 is dependent on the interfacial impedance (Rct and Cint). 
By fitting the measured impedance spectrum with the equivalent circuit model of 
laser writing electrodes shown in Figure 2, the values for each circuit element in Figure 2 
are found as follows, Rwire = 450 Ω, Cint = 0.7 µF, Rct = 30 kΩ, Rs = 500 Ω and Cs = 6.1 pF. 
The fitting curves along with the measured impedance data are shown in Figure 27. At low 
frequency (below 100 kHz), the electrical current between an electrode pair predominately 
takes the path formed by Cint and Rs.  
7.2 Reagents and samples 
20 M BPA aptamer in ultrapure water is used for incubation. Analytical BPA 
samples are prepared as 0.1 fM, 1.0 fM, 10 fM, 100 fM and 1 pM BPA in ultrapure water. 
Surface water samples are collected from Tennessee River near a waste water treatment 
plant in Knoxville and are diluted at 1:1,000,000 in ultrapure water prior to testing. No 
filtering is performed. 
7.3 Capacitance change with time during assay 
Ultrapure (Mili-Q) water as the background solution is also tested as the control. 
Each measurement is performed with an AC signal of 300 mV, 1 kHz for 20 seconds. As 
shown in Figure 28, the negative samples of 10 pM BPS (0.14 %/min) and BPF 
(0.35 %/min), and the control sample (-0.66 %/min) exhibited virtually no measurable shift 
in capacitance, while the positive samples containing trace BPA in water, gave a 
capacitance change of -19.39 %/min, -21.40 %/min, -29.65 %/min, -38.20 %/min and -
44.10 %/min at 1 fM, 10 fM, 100 fM and 1 pM respectively.  
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Figure 27 The measured impedance spectra (solid line) of the electrode cell and its 
equivalent circuit fitting (dotted line). 
 
 
Figure 28 Normalized capacitance changes of control, BPA, BPS and BPF samples with 
time. 
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7.4 Working condition optimization 
Based on Equation 3.2, ACEO flow velocity is strongly dependent on the voltage 
and frequency. Therefore, AC voltage level and frequency need to be optimized to fully 
take advantage of ACEO effect. Figure 29 shows the results when optimizing AC voltage 
level and frequency. All the tests are performed with 1fM BPA in ultrapure (Mili-Q) water. 
First the sensor responses are measured with AC voltage level varied from 100 mV to 400 
mV at the frequency of 1 kHz. Figure 29(a) demonstrates that, the capacitive response 
decreased monotonically as the voltage increased from 100 mV to 400 mV, showing that 
higher AC voltage contributed to larger sensor response. When the voltage level is above 
300 mV, the increase in sensor response became limited, due to saturation of binding sites 
on the sensor. Therefore, the optimal voltage level is determined to be 300 mV. The control 
samples of ultrapure water exhibited a noise limited response ranged from -0.52 to 
1.26 %/min.  
Figure 29(b) illustrates the frequency dependence of the sensor under a 300 mV AC 
signal whose frequency varied from 500 Hz to 10 kHz, with a well-defined maximum 
response at 1 kHz. This is in agreement with the bell-shaped frequency dependence of 
ACEO velocity, validating that ACEO effect is indeed the responsible mechanism for rapid 
and sensitive detection. Therefore, AC signal of 300 mV at 1 kHz is used in all the 
subsequent experiments.  
7.5 Dose response 
0.1 fM to 1 pM BPA samples are tested on the sensor to obtain the sensor’s BPA 
dose response with an assay time of 20 seconds, and the results are shown in Figure 30 (a). 
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Figure 29 Response of control and 1 fM BPA samples (a) when using 1 kHz AC signal 
with its voltage varied from 100 mV to 400 mV and (b) when using 300 mV AC signal 
with its frequency varied from 500 Hz to 10 kHz. 
 
 
Figure 30 Detected dose response of BPA samples as a function of concentration by data 
obtained in (a) 20 seconds and (b) 10 seconds. 
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Each BPA concentration is tested in triplicate using a new sensor each time. The responses 
from the water samples again are shown to be negligible, -0.47±0.94 %/min. The response 
from DMSO which is used as solvent in initial stock solution preparations for all the test 
compounds is also tested. The final concentration of DMSO in working solutions of all test 
compounds is 1.0 ppm with a negligible response of dC/dt of -1.22±1.19 %/min. The 
magnitude of dC/dt, or |dC/dt|, increases monotonically with increasing BPA concentration 
from 0.1fM to 1pM, with -6.48±1.08 %/min for 100 aM BPA and -41.9±2.47 %/min for 
1pM BPA. The increase in |dC/dt| with BPA level is slower than logarithm dependence, 
again due to rapid saturation of binding sites at higher BPA concentrations. Therefore, the 
dependence of dC/dt on BPA concentration is approximated by both quadratic curve and 
linear fittings as follow:  
𝑦 = 1.468lg2𝑥 − 11.591lg𝑥 − 19.836                                                                         (7.1) 
𝑦 = −9.392lg𝑥 − 17.885                                                                                              (7.2) 
where x is the BPA concentration in fM and y is the capacitance change per minute, dC/dt. 
The correlation coefficient R2 is 0.989 and 0.943 for the quadratic curve and linear fitting 
respectively. Figure 30(b) demonstrates the sensor’s dose response based on the first 10 
seconds’ data points of the acquired sensor readout values. By analyzing the data of the 
first 10 seconds, binding sites’ saturation effects can be diminished, allowing the sensor to 
each a much lower LOD of 16.10 aM. Since the quadratic fitting gives a more precise 
description of the characteristic of the dose response, it is adopted in the subsequent 
analysis. 
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The limit of detection is found based on the fitting curve, which is defined as 3 
standard deviations (1.19 %/min) from the response of background control: DMSO (-
1.22±1.19 %/min). The cut-off dC/dt is found to be -4.78 %/min, which corresponds to a 
BPA concentration of 58.28 aM. 
7.6 Specificity 
BPA’s analogues BPS and BPF (bisphenol S and bisphenol F), and two of BPA 
metabolites, β-D-glucuronide and monosulfate salt, are used as interference or non-specific 
molecules to determine the specificity of the functionalized aptamer sensor. Their 
responses are shown in Figure 31. Tests are conducted with an AC signal of 300 mV and 
1 kHz applied to the sensor. BPA-G and BPA-M in Figure 31 represent BPA β-D-
glucuronide and monosulfate salt respectively. BPS and BPF samples are tested at 1 pM 
and 10 pM, and β-D-glucuronide and monosulfate salt are 100 fM and 10 pM. In Figure 
31, the control samples of ultrapure water (0.44±0.64 %/min) and dimethlsulfoxide, 
DMSO, (-1.22±1.19 %/min), and 1 fM and 10 fM BPA results are listed as well for 
comparison. BPS (4.22±0.66 %/min for 1 pM and 3.29±0.09 %/min for 10 pM), BPF 
(5.41±1.13 %/min for 1pM and 4.25±0.26 %/min for 10 pM), and monosulfate salt 
(7.91±5.44 %/min for 100 fM and 0.22±1.15 %/min for 10 pM) all yielded small negative 
responses. However, glucuronide salt (-11.90±2.36 %/min for 100 fM and -22.33±3.20 
%/min for 10 pM) yielded a positive response but only at much high level of 
concentrations. The 100 fM glucuronide salt’s response is calculated to be equivalent to 
BPA’s response at 0.23 fM, demonstrating that the sensor’s selectivity against glucuronide 
is 430:1. It is known the glucuronidation and sulfation of environmental phenols are the  
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Figure 31 Illustration of sensor specificity. The blue line is the sensor response of LOD 
(58.28 aM) 
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major BPA metabolic pathways identified in human and animals.[81] Our results indicate 
that proper dilutions would be necessary when the same aptamer is used for free BPA 
detection from biological matrices.  
7.7 Complex river samples 
In order to test the performance of the sensor in complex matrix, and to illustrate 
the selectivity against various non-specific compounds, two river water samples are 
collected near a local waste treatment plant and diluted 1:1,000,000 in ultrapure water prior 
to testing. The diluted river water samples are then spiked with 5 fM BPA and performed 
recovery tests. The percentage recovery (% Recovery) is calculated as:  
% Recovery =
𝑐𝑠𝑝𝑖𝑘𝑒𝑑 𝑟𝑖𝑣𝑒𝑟 𝑠𝑎𝑚𝑝𝑙𝑒−𝑐𝑢𝑛𝑠𝑝𝑖𝑘𝑒𝑑 𝑟𝑖𝑣𝑒𝑟 𝑠𝑎𝑚𝑝𝑙𝑒 
5 𝑓𝑀
×100%                                     (7.3) 
BPA concentration in the river water samples are found by using Equation 6.1, i.e. 
solving for x using the measured dC/dt as y. Table 3 shows the sensor response for river 
water samples with the corresponding concentration interpreted using Equation 6.1. 
Diluted surface water sampled from up and down streams yielded a measured 
concentration of 0.53 fM and 0.30 fM BPA, which corresponds to original BPA 
concentrations of 0.53 nM and 0.30 nM respectively. Those values are in agreement with 
BPA levels reported in the literature.[82],[83]. The subsequent recovery experiments 
obtained recovery rates of 83.61% and 100.70% for 5 fM BPA added to river water.  
Based on our study, the sensing mechanism can be summarized in Figure 32. 
Enhanced by ACEO effect, BPA particles are carried to the electrode’s surface by fluid 
flows during capacitance measurement, together with interference particles such as BPS. 
Since the aptamer deposited on the electrode’s surface can only bind with BPA specifically,  
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Table 3 Surface water samples detection and recoveries. 
Sample dC/dt 
[%/min] 
Interpreted Concentration 
[fM] 
Recovery 
[%] 
Downstream -16.48±0.63 0.53  
Mixed with 5 fM sample -26.97±1.59 4.71 83.61 
Upstream -13.49±1.25 0.31  
Mixed with 5 fM sample -27.49±1.83 5.34 100.70 
 
 
 
 
 
 
Figure 32 Ultrasensitive capacitive sensors with directed movement of complex sample 
particles with applied the ACEO effect. 
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trace concentrations of BPA increase the layer thickness and decrease the interfacial 
capacitance. The nanostructured surface increases the area to immobilize aptamer, 
significantly increasing the sensitivity. 
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CHAPTER 8 
CONCLUSONS AND FUTURE WORK 
8.1 Conclusions 
This work demonstrates a low cost bio sensing platform that can be used for 
pathogens and infections diagnosis. By inducing ACEK for particles manipulation and 
acceleration, the sensing platform realizes sample enrichment and binding reaction 
measurement simultaneously, which leads to the sensor to be rapid, sensitive and specific. 
The achievements of this work include: 
(1) Different electrodes are investigated to study their suitability for direct 
capacitive sensing method in order to support rapid and low cost biosensing. 
Well-designed electrodes should have lower internal resistance and an 
interfacial-bulk capacitance ratio that is great than at least 103. 
(2) Much higher sensitivity in detection has been achieved using cross linkers, as 
well as by optimizing testing and incubation buffers. The improvement in 
sensor response from adopting linkers is significant in detecting influenza A 
virus and protein IgG . Tests of influenza A virus and protein IgG obtain LODs 
of 15 pg/mL and 4.513 fg/mL respectively in 30 seconds. However, without 
linker modification on sensor electrodes, the sensor shows quite small 
responses with an LOD of 1 ng/mL in protein IgG detection and is not even 
able to differentiate various concentrations of influenza A virus analytical 
samples. In addition to linkers, various incubation and testing buffers are also 
critical to bioparticles detection. After optimization of incubation and testing 
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buffers in nuclei acid detection, specific detection of human herpesvirus-1 
(HSV-1) dsDNA can be achieved within 30 seconds with an LOD of 1 pg/mL 
(6.5 copies/μL or 10.7 aM) in standard buffer, and 20 pg/mL (129.5 copies/μL 
or 0.21 fM) in  neat serum. 
(3) This bio-sensing platform can be expanded to chemical detection. Chemicals 
are very small molecules compared with virus or proteins, and DEP is not able 
to contribute in this application. AC electroosmotic effect, however, can be 
utilized for enrichment of small molecules, expanding the varieties of ACEK 
capacitive sensing, as well as the application in chemical detection. Detection 
of bisphenol A (BPA) by electrodes on flexible polyimide substrate possesses 
selectivity and an LOD of 58.28 aM corresponding to a rapid integration time 
of only 20 seconds. As for the complex samples, the sensor reaches 83.61% and 
100.70% recovery of two surface water samples.  
To summarize, this work demonstrates a successful development of innovative 
sensors for virus, protein, nuclei acid and small chemical molecules detection at 
ultra low concentration. This research provides a framework of low cost and 
practical sensing for on-site disease diagnosis and environmental monitoring. 
8.2 Future work 
Firstly, this developed bio-sensing platform is very promising for detecting target 
particles in complex matrix. Currently, the sensor is demonstrated to work with diluted 
serum samples.  In the future, we will try to integrate the sensor with a wicking material, 
such as a piece of filter paper, on top of the sensing area for sample load. By doing so, it is 
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anticipated that the wicking material will retain the blood cells and allow smaller particles 
such as proteins to move towards the sensor by capillary force, thus making it possible for 
the sensor to work with whole blood directly.  
Secondly, with integration of a board-level capacitance measuring and readout 
system, this platform can be realized into a portable device with multiple channels used for 
on-site sensing, monitoring and screening tests.  
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